Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
PZA Innovation
company
About
PZA Innovation is a biotechnology company that develops the PZA susceptibility testing method.
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $250.50K
- Industries
- Biopharma,Biotechnology
- Founded date
- Jan 1, 2020
- Operating Status
- Active
PZA Innovation develops reliable pyrazinamide, a first-line tuberculosis drug, susceptibility. They have sterilising activity in vivo. They use reverse engineering to find out the conditions under which pyrazinamide is active in vitro. That is, pyrazinamide acts on the living environment of mycobacterium tuberculosis in the host.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$250.50K
PZA Innovation has raised a total of
$250.50K
in funding over 2 rounds. Their latest funding was raised on
Dec 28, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 28, 2021 | Grant | $250.50K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
PZA Innovation is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
